Westwood Holdings Group Inc. purchased a new position in shares of Grail, Inc. (NASDAQ:GRAL – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 77,789 shares of the company’s stock, valued at approximately $1,389,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. State of Tennessee Department of Treasury bought a new position in Grail during the 4th quarter worth approximately $28,000. Lindbrook Capital LLC bought a new position in Grail during the 4th quarter worth approximately $28,000. Sterling Capital Management LLC bought a new stake in shares of Grail in the 4th quarter worth approximately $29,000. Wellington Shields Capital Management LLC bought a new stake in shares of Grail in the 4th quarter worth approximately $33,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Grail in the 4th quarter worth approximately $41,000.
Grail Stock Performance
Shares of GRAL stock opened at $39.32 on Wednesday. The firm has a market cap of $1.41 billion and a P/E ratio of -0.64. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99. The business’s 50 day moving average price is $30.41 and its 200-day moving average price is $27.00.
Insider Activity at Grail
In related news, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the sale, the chief executive officer now directly owns 828,662 shares in the company, valued at $25,862,541.02. The trade was a 0.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the sale, the chief financial officer now owns 335,170 shares in the company, valued at $10,457,304. This represents a 0.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 194,948 shares of company stock worth $6,583,130 over the last ninety days. 1.85% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on GRAL shares. Morgan Stanley lifted their price objective on Grail from $16.00 to $20.00 and gave the stock an “equal weight” rating in a research report on Tuesday, March 18th. Canaccord Genuity Group lifted their price objective on Grail from $32.00 to $43.00 and gave the stock a “buy” rating in a research report on Wednesday, May 14th.
View Our Latest Analysis on GRAL
Grail Company Profile
GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.
Further Reading
- Five stocks we like better than Grail
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Top 5 Stocks Hedge Funds Are Buying Right Now
- Why Invest in 5G? How to Invest in 5G Stocks
- Viking Holdings Posts Strong Q1, Eyes Growth Ahead
- High Flyers: 3 Natural Gas Stocks for March 2022
- 2 Reasons Netflix’s 40% Rally Is Far From Over
Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Grail, Inc. (NASDAQ:GRAL – Free Report).
Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.